Company Filing History:
Years Active: 2005-2015
Title: Innovations of Chandeshwar Nath
Introduction
Chandeshwar Nath is a prominent inventor based in Lucknow, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating various medical conditions. With a total of four patents to his name, his work focuses on bioactive extracts and their applications in psychosis and diabetes management.
Latest Patents
Chandeshwar Nath's latest patents include groundbreaking research on bioactive extracts and their fractions. One of his notable inventions relates to the isolation of compounds from these extracts, which have shown promise in treating psychosis. The research highlights the antipsychotic activity of specific leaf alkaloids, including tetrahydroalstonine and reserpiline, demonstrating their effectiveness without causing extra pyramidal symptoms. Another significant patent involves oxy substituted flavones, which exhibit antihyperglycemic and antidyslipidemic properties. This invention provides a method for controlling type II diabetes and associated hyperlipidemic conditions through the administration of these novel compounds.
Career Highlights
Chandeshwar Nath is affiliated with the Council of Scientific & Industrial Research, where he conducts his research and development activities. His work has garnered attention for its innovative approach to addressing critical health issues through scientific exploration and discovery.
Collaborations
Chandeshwar Nath has collaborated with notable colleagues, including Ram Pratap and Raghwendra Pal, to further enhance the impact of his research. These collaborations have contributed to the advancement of knowledge in the field of pharmacology and the development of effective treatments.
Conclusion
Chandeshwar Nath's contributions to the field of pharmaceuticals through his innovative patents reflect his dedication to improving health outcomes. His research on bioactive extracts and their applications in treating psychosis and diabetes showcases the potential of scientific innovation in addressing pressing medical challenges.